Introduction: In 2011, the National Heart, Lung, and Blood Institute recommended universal lipid screening of all youth and adolescents at ages 9-11 and 17-21 years of age. In contrast, the U.S. Preventative Services Task Force statement could not recommend screening one way or another. The difference was due to limited data on the effect of early screening and treatment, especially in the 20-35 year old population, and limited cost-effectiveness evidence for universal screening. Purpose: The purpose of this study was to examine real-world temporal trends in lipid testing, dyslipidemia, and lipid lowering therapy (LTT) utilization in ages 2-30 for 2007-2012, and to estimate the cost-effectiveness of universal vs. selective pediatric lipi...
ABSTRACT This clinical report replaces the 1998 policy statement from the American Academy of Pediat...
BackgroundRaised low-density lipoprotein cholesterol (LDL-C) in young adulthood (aged 18-39 years) i...
Aim: Screening of dyslipidemia in childhood has been controversial. While some guidelines recommend ...
Introduction: In 2011, the National Heart, Lung, and Blood Institute recommended universal lipid scr...
OBJECTIVE: To compare the number of children needed to screen to identify a case of childhood dyslip...
Background/Aims: Atherosclerotic cardiovascular disease (ASCVD) accounts for 1 in every 3 deaths in ...
Universal lipid screening (ULS) is recommended for all 9- to 11-year-old children. We investigated U...
ImportanceElevations in levels of total, low-density lipoprotein, and non-high-density lipoprotein c...
Purpose of reviewThe purpose of this study is to review the National Heart Lung and Blood Institute ...
Cardiovascular disease is the leading cause of death in the United States and is linked to childhood...
Universal Pediatric Lipid Screening Guidelines are currently based on expert opinion only. Bright Fu...
BACKGROUND: No clinical trials have assessed the effects or cost-effectiveness of sequential screeni...
BACKGROUND: Lipid-lowering therapy is costly but effective at reducing coronary heart disease (CHD) ...
Aims Dyslipidaemia is a treatable risk factor for atherosclerosis, and the 2011 National Heart, Lung...
Summary: The purpose of the study was to try to detect at an early stage the important cardiovascula...
ABSTRACT This clinical report replaces the 1998 policy statement from the American Academy of Pediat...
BackgroundRaised low-density lipoprotein cholesterol (LDL-C) in young adulthood (aged 18-39 years) i...
Aim: Screening of dyslipidemia in childhood has been controversial. While some guidelines recommend ...
Introduction: In 2011, the National Heart, Lung, and Blood Institute recommended universal lipid scr...
OBJECTIVE: To compare the number of children needed to screen to identify a case of childhood dyslip...
Background/Aims: Atherosclerotic cardiovascular disease (ASCVD) accounts for 1 in every 3 deaths in ...
Universal lipid screening (ULS) is recommended for all 9- to 11-year-old children. We investigated U...
ImportanceElevations in levels of total, low-density lipoprotein, and non-high-density lipoprotein c...
Purpose of reviewThe purpose of this study is to review the National Heart Lung and Blood Institute ...
Cardiovascular disease is the leading cause of death in the United States and is linked to childhood...
Universal Pediatric Lipid Screening Guidelines are currently based on expert opinion only. Bright Fu...
BACKGROUND: No clinical trials have assessed the effects or cost-effectiveness of sequential screeni...
BACKGROUND: Lipid-lowering therapy is costly but effective at reducing coronary heart disease (CHD) ...
Aims Dyslipidaemia is a treatable risk factor for atherosclerosis, and the 2011 National Heart, Lung...
Summary: The purpose of the study was to try to detect at an early stage the important cardiovascula...
ABSTRACT This clinical report replaces the 1998 policy statement from the American Academy of Pediat...
BackgroundRaised low-density lipoprotein cholesterol (LDL-C) in young adulthood (aged 18-39 years) i...
Aim: Screening of dyslipidemia in childhood has been controversial. While some guidelines recommend ...